CDIBCertificate of Degree of Indian Blood
CDIBChina Development Industrial Bank (Taiwan)
CDIBCustoms Drug Investigation Bureau (Hong Kong)
CDIBCommunity Diversity Issues Board
CDIBCanadian Defence Industrial Base
CDIBCystic Dilatation of Intrahepatic Biliary System (pediatric surgery)
References in periodicals archive ?
According to CDIB, the partnership with Govtor Capital is helping the bank to enter the financial market in East China by utilizing Jiangsu Province as a spring board.
Developed by local team, AFEIS can flexibly cater to customization needs of CDIB while has full sub-system features.
Our ancestors are on the rolls but we have not been accorded the right to be a part of that program where we would be able to have a CDIB card and entitle us to those benefits.
CDIB Capital (International) Corporation ("CDIB Capital") operates as the overseas investing arm of China Development Financial Holdings Corporation (CDFH), one of the largest and longest standing merchant banking groups in Asia with over US$11 billion in assets.
CDIB expects the tie-up to give it a foothold in expanding into the Japanese market, including investment in venture businesses, the sources said.
Xanthus' existing investors were the sole participants in this round including, Oxford Bioscience Partners, HealthCare Ventures, GeneChem, GIMV, Hambrecht & Quist Capital Management, Still River Fund, Neomed, Kestrel Ventures, CDP Capital, CDIB BioScience Ventures, and Yasuda.
3, 2015 /PRNewswire/ -- Eaton Partners ("Eaton"), the largest independent, partner-owned, global fund placement agent, is pleased to have served as the exclusive placement agent for CDIB Capital Asia Partners L.
CDIB has pursued increasing diversification in terms of geographic and industry distribution of its direct investment portfolio over the past few years.
CDIB BioScience Venture Management (CBVM) is one of the largest dedicated life science funds from Taiwan.
Elixir is backed by MPM Capital, Oxford BioScience Partners, ARCH Venture Partners, CDIB Ventures, JAFCO, YFY Biotech Management Company and other leading industry investors.
The round was led by CDIB Venture Capital with participation by existing investors.